Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – In men, the risk of developing breast cancer is increased by having a first-degree relative with breast cancer, being obese and physically inactive,…
Douglas S. Hawkins, MD, Associate Professor, Pediatrics, Seattle Children’s Hospital, Seattle WA, discusses errors with orally administered chemotherapy medication in children. References and Resources Taylor JA, Winter L,…
NEW YORK (Reuters Health) – Detection of JC virus, an important cause of progressive multifocal leukoencephalopathy (PML) in immunosuppressed patients, is not a good predictor of PML risk…
Dr. Susan Love discusses her partnership with the Avon Foundation and the origins of the “Army of Women” fighting to prevent and cure breast cancer. References and Resources…
NEW YORK (Reuters Health) – High-dose therapy (HDT) combined with autologous stem cell transplantation (ASCT) may prolong remissions and improve survival in patients with chemoresistant Hodgkin lymphoma, researchers…
NEW YORK (Reuters Health) – In evaluating screening mammograms for breast cancer, a single reader with computer assistance can perform just as well as two readers, the results…
NEW YORK (Reuters Health) – The results of a new study indicate that 80% of cancer patients undergoing radiation therapy do not use medications to combat pain. Many…
NEW YORK (Reuters Health) – While raloxifene and tamoxifen are broadly similar in reducing breast cancer risk, raloxifene appears also to lower the odds of developing endometrial cancer,…
NEW YORK (Reuters Health) – The risk of lung cancer is increased in patients with rheumatoid arthritis, even after taking into account the effects of tobacco and asbestos…
NEW YORK (Reuters Health) – If an initial screening colonoscopy indicates no colorectal neoplasia, the odds that a malignancy will develop in the next 5 years is “extremely…
